It has been shown that IgE binding to FcεRI on mast cells results in increased FcεRI expression, which in turn enhances IgE-dependent chemical mediator release from mast cells. Therefore, prevention of the IgE-mediated FcεRI up-regulation would be a promising strategy for management of allergic disorders. However, the mechanism of IgE-mediated FcεRI up-regulation has not been fully elucidated. In this study, we analyzed kinetics of FcεRI on peritoneal mast cells and bone marrow-derived mast cells. In the presence of brefeldin A, which prevented transport of new FcεRI molecules to the cell surface, levels of IgE-free FcεRI on mast cells decreased drastically during culture, whereas those of IgE-bound FcεRI were stable. In contrast, levels of FcγRIII on the same cells were stable even in the absence of its ligand, indicating that FcεRI α-chain, but not β- and γ-chains, was responsible for the instability of IgE-free FcεRI. As far as we analyzed, there was no evidence to support the idea that IgE binding to FcεRI facilitated synthesis and/or transport of FcεRI to the cell surface. Therefore, the stabilization and accumulation of FcεRI on the cell surface through IgE binding appears to be the major mechanism of IgE-mediated FcεRI up-regulation.